Hudson Bay Capital Management
KZIA

Hudson Bay Capital Management’s Kazia Therapeutics KZIA Stock Holding History

Hudson Bay Capital Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-300
Closed -$241K – 236
2015
Q2 		$241K Buy
+300
New +$340K 0.01% 214

Other funds holding KZIA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Hudson Bay Capital Management's KZIA Position: Q3 2015 in Review

Hudson Bay Capital Management sold out of Kazia Therapeutics (KZIA) in Q3 2015, closing a stake of 300 shares — an estimated $241K sold.

Hudson Bay Capital Management first reported a position in KZIA in Q2 2015 and held it in 1 quarter. The position peaked at $241K in Q2 2015. 7 funds tracked by Wall St. Rank hold KZIA as of Q3 2015.

  • Hudson Bay Capital Management reported no remaining Kazia Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Hudson Bay Capital Management sold 300 Kazia Therapeutics shares in Q3 2015, an estimated $241K.
  • Hudson Bay Capital Management first reported a position in Kazia Therapeutics in Q2 2015 and held it in 1 quarter.
  • Hudson Bay Capital Management's Kazia Therapeutics position peaked at $241K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2015.

Based on Hudson Bay Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.